ALKEM NEWS why is Alkem Laboratories Ltd. price falling or rising
ALKEM NEWS reasons for why stock price of Alkem Laboratories Ltd. is falling or rising
ALKEM Alkem Laboratories is falling or rising technical reasons
Technical analysis forecast of Alkem Laboratories Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Alkem Laboratories ALKEM at this time. Stock is rising and might rise more.
It appears as if Alkem Laboratories ALKEM gave a large move recently.
Stock of Alkem Laboratories (ALKEM) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
Although my analysis for Alkem Laboratories is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 5695.7, for a target of 5617.1 or 5551.58
ALKEM Alkem Laboratories is falling or rising NEWS fundamental reasons
Company Announcement Alkem Laboratories Limited has informed the Exchange regarding a press release dated November 03, 2025, titled "Alkem and IIT Bombay announce strategic collaboration to set up advanced research centre for immuno-therapeutics and regenerative medicines". - NEWS as on 2025-11-03
Company Announcement Alkem Laboratories Limited has informed the Exchange about Schedule of meet - NEWS as on 2025-10-28
Board Meeting to discuss Financial Results Notice of meeting of the Board of Directors of the Company scheduled to be held on Thursday, 13th November, 2025, inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quart - NEWS as on 2025-10-24
Company Announcement - NEWS as on 2025-10-24
Company Announcement Alkem Laboratories Limited has informed the Exchange regarding a press release dated September 22, 2025, titled "Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer.". - NEWS as on 2025-09-23
Company Announcement Alkem Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 25, 2025. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. - NEWS as on 2025-08-26
Company Announcement Alkem Laboratories Limited has informed the Exchange regarding a press release dated August 19, 2025, titled "Alkem launches Olesoft Trucera, an advanced ceramide-boosting - NEWS as on 2025-08-19
More announcements and NEWS
ALKEM Alkem Laboratories Ltd. current price & indicator signals
Recent prices of ALKEM Alkem Laboratories Ltd. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 07 Fri Nov 2025 | 5668.50 | 5571.50 to 5687.50 | 0.44% | 1.82 times |
| 06 Thu Nov 2025 | 5643.50 | 5631.00 to 5704.00 | -0.36% | 1.22 times |
| 04 Tue Nov 2025 | 5664.00 | 5630.50 to 5719.00 | 0.63% | 1.91 times |
| 03 Mon Nov 2025 | 5628.50 | 5499.00 to 5637.50 | 2.22% | 0.61 times |
| 31 Fri Oct 2025 | 5506.50 | 5477.00 to 5531.00 | -0.33% | 1.43 times |
| 30 Thu Oct 2025 | 5525.00 | 5454.00 to 5540.50 | -0.18% | 0.63 times |
| 29 Wed Oct 2025 | 5535.00 | 5415.50 to 5545.00 | 1.9% | 1.01 times |
| 28 Tue Oct 2025 | 5432.00 | 5321.00 to 5468.00 | -0.79% | 1.26 times |
| 27 Mon Oct 2025 | 5475.50 | 5440.50 to 5580.00 | -1.25% | 0.57 times |
| 24 Fri Oct 2025 | 5545.00 | 5489.50 to 5569.00 | 0.2% | 0.95 times |
| 23 Thu Oct 2025 | 5534.00 | 5519.50 to 5599.00 | -0.24% | 0.4 times |
| 21 Tue Oct 2025 | 5547.50 | 5508.50 to 5585.50 | -0.17% | 0.14 times |
Videos related to: ALKEM NEWS why is Alkem Laboratories Ltd. price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance


